Visionsense develops visualization solutions that bring natural stereoscopic sight to minimally invasive surgery. Using sensor technology and proprietary software, the Visionsense system delivers depth perception, 3D HD-resolution images, and maneuvering flexibility in the smallest access diameters. With stereovision capabilities, surgeons gain enhanced tissue understanding, improved hand-eye coordination, and the confidence to use advanced articulating surgical tools.
The companys VSiii solution is based on a small-diameter (starting at 4 millimeters), single-channel endoscope that delivers visual information to a stereoscopic camera that imitates an insects compound eye. The VSiii system can be used in minimally invasive neurosurgery, ENT, arthroscopy (CE only), and general surgery procedures. It has been cleared by the FDA and CE and is used clinically on a regular basis worldwide.
Cumulative Funding Raised Over Time ($)
Employees Over Time
VisionSense Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Apr 11, 2018
www.calcalistech.com
Medtronic Buys Medical Visualization Company Visionsense for $65 Million
#Acquisition
Apr 9, 2018
www.globes.co.il
Exclusive: Medtronic to buy Israeli co Visionsense for $75m
#Acquisition
Nov 6, 2017
www.novuslight.com
Light Technologies in Brain Research
undefined
May 16, 2017
www.prnewswire.com
Visionsense files for an Inter Partes Review (IPR) against Novadaq's US Patent 8,892,190